Drug Type Small molecule drug |
Synonyms 아이플클리어점안액 |
Action inhibitors, antagonists |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors), DHPS inhibitors(Dihydropteroate synthase inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (16 Dec 2022), |
Regulation- |
Molecular FormulaC42H60K2O16 |
InChIKeyBIVBRWYINDPWKA-VLQRKCJKSA-L |
CAS Registry68797-35-3 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Conjunctivitis | South Korea | 16 Dec 2022 | |
| Hordeolum | South Korea | 16 Dec 2022 | |
| Blepharitis | - | - | - |
| Conjunctivitis, Bacterial | - | - | - |





